|
Patient Centered Care in HNSCC February 17, 2017 Drs. Robert Ferris and Laura Chow discuss some of the practicalities involved in treating patients with HNSCC with checkpoint inhibitors. |
|
The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in NSCLC January 18, 2017 Learn about the use of checkpoint inhibitors in patients with NSCLC. |
|
Determining the Best Treatment Algorithm for Patients with Head and Neck Cancer December 20, 2016 Experts discuss treatment strategies for one patient with recurrent HNSCC and one with locally advanced HNSCC. |
|
Strengthening Lung Cancer Team Connections to Improve Outcomes with Immunotherapy December 16, 2016 Watch as an oncologist, pharmacist, and nurse discuss challenges and best practices for working in a team environmen |
|
Clinical Challenges in Melanoma: Progressive Disease December 7, 2016 Imaging scans suggest this patient's melanoma has progressed, but has it? Watch this case to see how it develops.
|
|
New Frontiers in Decision Making: Immunotherapy in Advanced Non-Squamous NSCLC December 6, 2016 Follow a patient with advanced adenocarcinoma to learn about the use and management of immune checkpoint inhibitors |
|
New Frontiers in Decision Making: Adverse Events With Immunotherapy in NSCLC December 6, 2016 Use a patient case to learn about managing adverse events with immunotherapy in patients with NSCLC.
|
|
Advancing the Care in Thoracic Cancer: Emerging Treatment Options November 30, 2016 Read 3 articles that review immunotherapy treatment options in mesothelioma, small cell lung cancer, and non-small cell lung cancer.
|
|
Optimizing Outcomes in Metastatic Melanoma: A Case Challenge November 22, 2016 Review appropriate treatment regimens for patients with metastatic melanoma
|
|
Essential Concepts in Harnessing the Immune System in Head and Neck Cancer November 15, 2016 Dr. Tanguy Seiwert explores the emerging role for immunotherapy in head and neck cancer.
|
|
The Nurse View: Overcoming Challenges Associated with Cancer Immunotherapy November 11, 2016 Experts discuss the role of nursing for setting expectations and managing irAEs in patients with melanoma receiving immunotherapy.
|
|
Clinical Challenges in Melanoma: Frontline October 21, 2016 A patient undergoing treatment for metastatic melanoma experiences some unusual symptoms. Watch this case to figure out what is going on.
|
|
New Frontiers in Decision Making: Immunotherapy in Advanced Squamous Cell NSCLC October 21, 2016 Follow a patient with advanced squamous cell NSCLC to learn about the use and management of immune checkpoint inhibitors. |
|
Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma October 14, 2016 Dr. Stephen Ansell discusses the emerging role of immunotherapy in the management of patients with Hodgkin lymphoma. |
|
Patient-Centered Care in Metastatic Renal Cell Carcinoma September 21, 2016 Explore some of the main issues in the treatment of advanced RCC through 2 case |
|
Priming T-Cells: Do We Understand the Strategies? September 15, 2016 Three articles examine the role of T cells in the anticancer immune response and how they are being used in therapy |
|
Emerging Considerations in the Use of Immune Checkpoints in Lung Cancer September 14, 2016 Drs. Weiss, Borghaei, and Patel discuss the clinical data and practical implications for using checkpoint inhibitors to treat lung cancer. |
|
Pulmonologist Perspectives: How Will the Use of Immune Checkpoint Inhibitors Affect My Practice? August 31, 2016 Learn how treatment of NSCLC with checkpoint inhibitors will affect your clinical outlook. |
|
Spotlight on Immuno-Oncology in Melanoma August 31, 2016 Drs. Weber, Luke, and Gangadhar discuss the latest updates to existing immunotherapies and examine where the future may lie
|
|
Cancer Immunotherapy: Pathways and Mechanisms of Actions August 24, 2016 In these 3 columns, experts discuss the basics of the immune system as well as existing and novel targets for cancer immunotherapy.
|
|
Hiding in Plain Sight: How Cancer Evades the Immune System August 24, 2016 Dr. Robert Ferris reviews the working of the immune system and the development of cancer.
|
|
Clinical Considerations in the Use of Checkpoint Inhibitors for Gastrointestinal March 18, 2016 Watch Drs Shah and Kelly discuss the latest data presented at the GI Cancer Meeting in San Francisco.
|
|
Clinical Considerations in the Use of Checkpoint Inhibitors -- Genitourinary February 23, 2016 Watch Drs Plimack and McDermott review some of the data presented at the 2016 GU Cancer Meeting.
|
|
Integrating Novel Immunotherapies in the Management of Advanced NSCLC February 22, 2016 Drs. Chaft and Hellmann review tailored treatment approaches for patients with advanced NSCLC.
|
|
Clinical Considerations in the Use of Checkpoint Inhibitors -- Breast Cancer January 26, 2016 Drs. Burris and Yee talk about immunotherapy and how this new therapeutic class is being developed for patients with breast cancer. |
|
A Multidisciplinary Approach in Advanced NSCLC in the Era of Immuno-Oncology January 4, 2016 Join the experts as aspects of multidisciplinary care for the early diagnosis and treatment of patients with advanced NSCLC are explored. |
|
Systemic Therapy for Advanced Melanoma: Making the Right Choices December 22, 2015 Faculty reviews how to incorporate the results from clinical trials into practice for metastatic melanoma. |
|
Staging, Biomarker Testing, and Treatment in Advanced NSCLC December 18, 2015 Dr. Praveen Chenna reviews the role of the pulmonologist in the diagnosis and management of patients with advanced non-small cell lung cancer. |
|
Checkpoint Inhibitors: The Challenge of Immune-Mediated Side Effects November 24, 2015 Read these 2 cases to explore strategies for managing immune-related adverse effects in melanoma and NSCLC. |
|
Clinical Considerations in the Use of Immune Checkpoint Inhibitors: Head and Neck Cancer October 30, 2015 Drs. Robert Ferris and Tanguy Seiwert explore the possibilities for using immunotherapy in patients with head and neck cancer. |
|
Patient-Centered Management in Advanced Non-Small Cell Lung Cancer October 30, 2015 Join Drs. Spigel and Paz-Ares Rodríguez and Ms Reed as they explore the utility of immunotherapy for patients with NSCLC. |
|
Incorporating Patient-Centered Management in Metastatic Melanoma September 25, 2015 Dr. Geoff Gibney provides two cases to examine some of the decision-making surrounding treating patients with metastatic melanoma. |
|
Waiting Room: Immunotherapy for Metastatic Melanoma – Clinical Practice Challenges September 25, 2015 Engage in interactive virtual patient cases to help inform clinical practice for metastatic melanoma. Choose from the following challenges:
|
|
Therapeutic Decision Making in Metastatic Melanoma August 6, 2015 Listen to faculty discuss how to incorporate the results from clinical trials into practice for metastatic melanoma. |
|
Clinical Considerations in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC July 17, 2015 Drs. Govindan and Herbst discuss immunotherapy, appropriate patient selection, and side effects of treatment. |
|
New Horizons in Cancer Immunotherapy: Management of Metastatic RCC June 29, 2015 Drs. Rini and Fishman discuss how to incorporate the new immunotherapies into the existing paradigms for mRCC. |
|
Essential Concepts in the Use of Immuno-Oncologic Agents in Advanced Lung Cancer June 26, 2015 Drs. Govindan, Rizvi and Garon discuss the use of emerging immunotherapeutic agents in patients with advanced NSCLC. |
|
Key Concepts in the Segue Between the Immune System and Cancer June 16, 2015 These 3 columns review the current state of the science to modulate the immune system to achieve therapeutic goals. |
|
Is the Revolution Now? Harnessing the Immune System to Target Hard-to-Treat Cancers June 10, 2015 Listen to faculty review the mechanisms of immune escape by cancer, the importance of modulating immune checkpoint interactions, and the paradigm shift in treatment. |
|
Removing the Escape Hatch: Restoring Immune System Activation and Memory in Cancer May 22, 2015 Dr. Michael Postow reviews the mechanisms by which cancer can escape the immune system and treatment approaches to overcome these processes. |
|
The Immunology of Genitourinary Cancers November 14, 2014 Drs. Brian Rini and Hiral Parekh discuss the emergence of immunotherapy research and treatments in genitourinary malignancies. |
|
Immunotherapy in Melanoma: Evaluating Treatment Responses and Adverse Events September 25, 2014 Drs. Weber and Ribas discuss optimal strategies for the use of immunotherapy in patients with advanced melanoma. |
|
Unleashing the Immune System in Advanced NSCLC September 12, 2014 Listen in on a conversation between two experts on where we are now and where we are headed in the use of immunotherapy in advanced NSCLC |
|
Emerging Paradigms in the Treatment of Advanced Melanoma August 25, 2014 Drs.Weber, Margolin, and Robert discuss issues related to current and emerging immunotherapies for advanced melanoma. |
|
New Opportunities: Immunotherapies in Advanced NSCLC August 15, 2014 Interested in an update on use of immunotherapy in patients with advanced NSCLC? Get one here. |
|
Manipulating the Immune System in Melanoma to Restore Immune-Mediated Tumor Control June 19, 2014 Dr. Jeffrey Weber reviews the emergence of immunotherapy to treat advanced melanoma. |
|
Immune Checkpoint Inhibition: Unfettered T Cells Can Control and Eliminate Tumors May 28, 2014 Dr. Govindan leads a discussion with Dr Ferris and Dr Spigel on the application of immune strategies and therapies for cancer |
|
Tumor Immunity: Exploring the Role of a Checkpoint May 13, 2014 Review this illustrated discussion from Dr. Nora Disis to learn more about the immune system and checkpoints in the development and treatment of tumors. |
|
Concepts in Immuno-Oncology: Understanding the Key Players April 30, 2014 Learn about adaptive immunity and immune checkpoints.
|